Correlation Between Center Laboratories and GeneFerm Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Center Laboratories and GeneFerm Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Center Laboratories and GeneFerm Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Center Laboratories and GeneFerm Biotechnology Co, you can compare the effects of market volatilities on Center Laboratories and GeneFerm Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Center Laboratories with a short position of GeneFerm Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Center Laboratories and GeneFerm Biotechnology.

Diversification Opportunities for Center Laboratories and GeneFerm Biotechnology

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Center and GeneFerm is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Center Laboratories and GeneFerm Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneFerm Biotechnology and Center Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Center Laboratories are associated (or correlated) with GeneFerm Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneFerm Biotechnology has no effect on the direction of Center Laboratories i.e., Center Laboratories and GeneFerm Biotechnology go up and down completely randomly.

Pair Corralation between Center Laboratories and GeneFerm Biotechnology

Assuming the 90 days trading horizon Center Laboratories is expected to under-perform the GeneFerm Biotechnology. In addition to that, Center Laboratories is 2.5 times more volatile than GeneFerm Biotechnology Co. It trades about -0.37 of its total potential returns per unit of risk. GeneFerm Biotechnology Co is currently generating about -0.28 per unit of volatility. If you would invest  5,010  in GeneFerm Biotechnology Co on September 24, 2024 and sell it today you would lose (285.00) from holding GeneFerm Biotechnology Co or give up 5.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Center Laboratories  vs.  GeneFerm Biotechnology Co

 Performance 
       Timeline  
Center Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Center Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Center Laboratories is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
GeneFerm Biotechnology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in GeneFerm Biotechnology Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, GeneFerm Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Center Laboratories and GeneFerm Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Center Laboratories and GeneFerm Biotechnology

The main advantage of trading using opposite Center Laboratories and GeneFerm Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Center Laboratories position performs unexpectedly, GeneFerm Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneFerm Biotechnology will offset losses from the drop in GeneFerm Biotechnology's long position.
The idea behind Center Laboratories and GeneFerm Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals